DJO Primed for Growth and Expansion in 2021

DJO's logo

DJO reported 1Q21 orthopedic revenue of USD $115.1 million, +9.8% vs. 1Q20. The company’s busy first quarter included an announcement of Colfax’s intent to split into two companies, the completion of a $700 million equity offering and the acquisition of MedShape to expand DJO’s foot and ankle business.

To date, Colfax invested $225 million...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0